Bristol Myers Squibb Construction in Progress (Quarterly) Analysis

Bristol Myers Squibb Co. (BMY)

60.66 +0.36 (+0.60%) USD | NYSE | Feb 20, 16:00

60.66 0.00 (0.00%) After-Hours: 20:00

View Construction in Progress (Quarterly) for BMY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Construction in Progress (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Construction in Progress Definition

Start Trial

Construction in Progress is a long-term asset that records the costs associated directly with the building of an asset.

View Construction in Progress (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Construction in Progress (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Gilead Sciences, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Janux Therapeutics, Inc.	--
Moderna, Inc.	Upgrade